These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37582537)

  • 1. Balancing Innovation, 'Ordre Public' and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law.
    Matthews D; Minssen T; Nordberg A
    Eur J Health Law; 2022 Apr; 29(3-5):562-588. PubMed ID: 37582537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethics and patentability in biotechnology.
    Witek R
    Sci Eng Ethics; 2005 Jan; 11(1):105-11. PubMed ID: 15727006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent protection for stem cell procedures under the law of the European Union.
    Spranger TM
    Med Etika Bioet; 2003; 10(1-2):4-8. PubMed ID: 16294439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human genome editing: how to prevent rogue actors.
    Townsend BA
    BMC Med Ethics; 2020 Oct; 21(1):95. PubMed ID: 33023591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapting the ordre public and morality exclusion of European patent law to accommodate emerging technologies.
    Pila J
    Nat Biotechnol; 2020 May; 38(5):555-557. PubMed ID: 32393908
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of bioethics on patentability of inventions.
    Devaiah VH
    Indian J Med Ethics; 2010; 7(1):14-7. PubMed ID: 20166289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent Ethics: The Misalignment of Views Between the Patent System and the Wider Society.
    Forsberg EM; Hanssen AB; Nielsen HM; Olesen I
    Sci Eng Ethics; 2018 Oct; 24(5):1551-1576. PubMed ID: 28812235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Private and public values of innovation: A patent analysis of synthetic biology.
    Ribeiro B; Shapira P
    Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are patents for methods of medical treatment contrary to the ordre public and morality or "generally inconvenient"?
    Mitnovetski O; Nicol D
    J Med Ethics; 2004 Oct; 30(5):470-5; discussion 475-7. PubMed ID: 15467080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene editing of human embryos is not contrary to human rights law: A reply to Drabiak.
    Boggio A; Yotova R
    Bioethics; 2021 Nov; 35(9):956-963. PubMed ID: 34453362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patenting biotechnologies: the European Union Directive 98/44/EC of the European parliament and of the council of 6th July 1998 on the legal protection of biotechnological inventions.
    Morelli Gradi G
    Forum (Genova); 1999; 9(3 Suppl 3):25-36. PubMed ID: 10607844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Australia's Policymakers Can Ethically Approach Human Germline Genome Editing Technology.
    Mangiapane M; Foong P
    J Law Med; 2022 Aug; 29(3):740-759. PubMed ID: 36056664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immoral gene: does it really exist?
    Zimmer FJ; Sethmann S
    Sci Eng Ethics; 2005 Jan; 11(1):97-104. PubMed ID: 15727005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japan's patent issues relating to life science therapeutic inventions.
    Tessensohn JA
    Expert Opin Ther Pat; 2014 Sep; 24(9):953-7. PubMed ID: 25089628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.
    Vasconcellos AG; Morel CM
    PLoS One; 2012; 7(10):e45569. PubMed ID: 23056208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Modification and Policymaking: The Relationship between Mitochondrial Replacement and Gene Editing.
    Cussins J; Lowthorp L
    New Bioeth; 2018 Apr; 24(1):74-94. PubMed ID: 29529982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summoning a New Artificial Intelligence Patent Model: In The Age Of Pandemic.
    Yanisky-Ravid S; Jin R
    SSRN; 2020 Jun; ():3619069. PubMed ID: 32714121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concerns.
    Nordberg A; Minssen T; Holm S; Horst M; Mortensen K; Møller BL
    J Law Biosci; 2018 May; 5(1):35-83. PubMed ID: 29707216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.